NGeneBio Co., Ltd. (354200) Price & Analysis

― Followers

354200 Stock Chart & Stats

$1621.00

$101.00(6.64%)

Jul 31, 2026

―

Day’s Range― - ―

52-Week Range$1,263.88 - $6,979.97

Previous CloseN/A

VolumeN/A

Average Volume (3M)N/A

Market Cap

₩24.46B

Enterprise Value$71.36K

Total Cash (Recent Filing)N/A

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)―

Beta0.11

Next Earnings

Aug 21, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-403.90

Shares Outstanding16,093,044

10 Day Avg. VolumeN/A

30 Day Avg. VolumeN/A

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

354200 FAQ

What was NGeneBio Co., Ltd.’s price range in the past 12 months?

NGeneBio Co., Ltd. lowest stock price was $1263.88 and its highest was $6979.97 in the past 12 months.

What is NGeneBio Co., Ltd.’s market cap?

NGeneBio Co., Ltd.’s market cap is ₩24.46B.

When is NGeneBio Co., Ltd.’s upcoming earnings report date?

NGeneBio Co., Ltd.’s upcoming earnings report date is Aug 21, 2026 which is in 19 days.

How were NGeneBio Co., Ltd.’s earnings last quarter?

NGeneBio Co., Ltd. released its earnings results on May 15, 2026. The company reported -$403.9 earnings per share for the quarter, missing the consensus estimate of N/A by -$403.9.

Is NGeneBio Co., Ltd. overvalued?

According to Wall Street analysts NGeneBio Co., Ltd.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does NGeneBio Co., Ltd. pay dividends?

NGeneBio Co., Ltd. does not currently pay dividends.

What is NGeneBio Co., Ltd.’s EPS estimate?

NGeneBio Co., Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does NGeneBio Co., Ltd. have?

NGeneBio Co., Ltd. has 16,093,044 shares outstanding.

What happened to NGeneBio Co., Ltd.’s price movement after its last earnings report?

NGeneBio Co., Ltd. reported an EPS of -$403.9 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 13.04%.

Which hedge fund is a major shareholder of NGeneBio Co., Ltd.?

Currently, no hedge funds are holding shares in KR:354200

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology